Skip to main content
. 2017 Nov 6;2017(11):CD011373. doi: 10.1002/14651858.CD011373.pub2
Study Reason for exclusion
Caluwé 2016 Wrong intervention: rivaroxaban versus rivaroxaban plus vitamin K2 versus vitamin K antagonist
Eriksson 2003a Pharmacokinetic/pharmacodynamic RCT of ximelagatran and melagatran
Koretsune 2015 Pharmacokinetic/pharmacodynamic RCT of 3 treatment regimens of edoxaban
Murray 2004 Pharmacokinetic/pharmacodynamic cross‐over RCT of 3 treatment regimens of argatroban

RCT ‐ randomised controlled trial